Luis Pereira De Almeida

Title: Luis Pereira De Almeida: Innovator in Genetic Therapy

Introduction

Luis Pereira De Almeida is a notable inventor based in Coimbra, Portugal. He has made significant contributions to the field of genetic therapy, particularly in the treatment of neurological disorders. His innovative work has the potential to impact the lives of many individuals affected by these conditions.

Latest Patents

Luis Pereira De Almeida holds a patent for an "Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias." This invention relates to a vector designed for use in the treatment of polyglutamine repeat spinocerebellar ataxia, which includes cholesterol 24-hydroxylase encoding nucleic acid. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Luis has worked with several prominent organizations. He has been associated with Brainvectis, a company focused on gene therapy, and the Institut National de la Santé et de la Recherche Médicale, which is dedicated to health and medical research. His work in these institutions has allowed him to further his research and contribute to significant advancements in the field.

Collaborations

Luis Pereira De Almeida has collaborated with notable colleagues, including Sandro Alves and Nathalie Cartier-Lacave. These partnerships have enriched his research and fostered innovation in genetic therapies.

Conclusion

Luis Pereira De Almeida is a pioneering inventor whose work in genetic therapy holds promise for treating neurological disorders. His contributions to the field are invaluable, and his ongoing research continues to inspire advancements in medical science.